ObjectiveTo summarize research progress of farnesoid X receptor (FXR) in regulation of hepatocellular carcinoma (HCC) and explore its potential clinical application value.MethodThe relevant literatures at home and abroad on the mechanism of FXR regulating occurrence and development of HCC were reviewed.ResultsIn the occurrence and development of HCC, the FXR expression could be down-regulated through the inflammation-related pathways and epigenetic silencing. The FXR mightbe play an important role in the regulatory mechanisms of down-regulation in the HCC, therapeutic targets, drug resistance, and so on.ConclusionFXR plays an important regulatory role in occurrence and development of HCC, which makes FXR might become a potential target in treatment of HCC.